FDA Duloxetine recall flags 7,100+ bottles of generic Cymbalta antidepressants
A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why
The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...
Thousands of duloxetine bottles, an antidepressant sold as Cymbalta, recalled over toxic chemical
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a ...
Antidepressant recall: FDA upgrades medication risk class to 2nd highest level in recall update
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...
FDA recalls over 7,000 bottles of antidepressant due to possible cancerous chemical
The FDA has recalled thousands of bottles of the antidepressant duloxetine, sold under brand name Cymbalta, due to the ...
FDA recalls more than 7,000 bottles of antidepressant duloxetine over toxic chemical
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant duloxetine over the presence of ...
Nationwide Antidepressant Recall Update As FDA Sets Risk Class
The recall of the Duloxetine Delayed-Release Capsules, produced by Towa Pharmaceutical Europe, was initiated on October 10 ...
FDA recalls over 7,000 bottles of antidepressant duloxetine
The recall was initiated due to the discovery of N-nitroso-duloxetine, a chemical impurity classified as a nitrosamine.
FDA recalls thousands of antidepressant bottles due to cancer-causing chemical
The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine ...